Lab Guide
A B C D E F
G H I J K L
M N O P Q R
S T U V W X
Y Z #

Test ID: Gentamicin
Gentamicin
Useful For

Monitoring therapeutic drug level to ensure adequate dosing and to avoid toxic side effects.

 

Method name and description

Kinetic Interaction of Microparticles in a Solution (KIMS)

Kinetic interaction of microparticles in solution (KIMS) as measured by changes in light transmission on the Roche cobas c-systems. Gentamicin antibody is covalently coupled to microparticles and the drug derivative is linked to a macromolecule. The kinetic interaction of microparticles in solutions is induced by binding of drug‑conjugate to the antibody on the microparticles and is inhibited by the presence of Gentamicin in the sample. A competitive reaction takes place between the drug conjugate and Gentamicin in the serum sample for binding to the Gentamicin antibody on the microparticles. The resulting kinetic interaction of microparticles is indirectly proportional to the amount of drug present in the sample.

Reporting name

Gentamicin

Clinical information

Gentamicin is an aminoglycoside antibiotic that displays broad spectrum, high potency, anti‑bacterial action for most susceptible organisms. It has been most successfully used in the treatment of serious infections especially those caused by gram‑negative bacilli.  In patients with pre‑existing renal damage or those to whom gentamicin has been administered for prolonged periods or in doses above the therapeutic range, hearing impairment and/or nephrotoxicity may develop. Therefore, monitoring of peak and trough gentamicin levels is critical in the prevention of these serious complications with the adjustment of dosage administration as indicated.

Aliases

Gentamicin

 

Specimen type / Specimen volume / Specimen container

Specimen type: Serum, Plasma

Minimum volume of sample: 1 mL

Serum: Plain tube (red or yellow top)

Plasma: Lithium heparin tube

 

Collection instructions / Special Precautions / Timing of collection

The time of blood collection must be indicated.


Trough: Just prior to next dose

Peak: 1-2 hour after the end of infusion

 

Storage and transport instructions

Storage: 1 week at 2 – 8°C;

              4 weeks at ‑20 °C 

Transport: 2-25°C 

Specimen Rejection Criteria

Grossly hemolyzed, icteric and lipemic samples, wrong collection container, insufficient sample and heat‑inactivated samples.

Biological reference intervals and clinical decision values

Therapeutic range:

Trough range:  < 2.0 ug/mL (mg/L)

Peak range: 5- 10 ug/mL (mg/L)

Turnaround time / Days and times test performed / Specimen retention time

Daily (24/7)

Turn-around time:

STAT: 1 hour

Routine: One working day

Specimen Retention: 4 days